All Resources

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Ontario Budget…

Learn more | View

Intellectual Property • November 06, 2024

Submission on Global Affairs Canada CUMSA Consultation

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • September 11, 2024

IMC Response to the PMPRB’s 2024 Discussion Guide on the Board’s Guidelines

Learn more | View

Economic Impact • July 29, 2024

The Canadian Research & Development Pharmaceutical Sector 2021

Learn more | View

July 02, 2024

Submission on Proposed Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • June 14, 2024

The Canadian Research and Development Pharmaceutical Sector, 2021

…economy in 2021. It builds on the annual reports produced since 2018, sponsored by Innovative Medicines Canada (IMC), an industry association representing patented medicine enterprises in Canada’s R&D pharmaceutical sector….

Learn more | View

Pharmacare • June 05, 2024

IMC Open Letter to Senators on Bill C‑64

Learn more | View

Pharmacare • May 23, 2024

IMC Submission to the Standing Committee of Health on Bill C-64

Learn more | View

Economic Impact • January 15, 2024

The Canadian Research & Development Pharmaceutical Sector 2020

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View